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Cerebrospinal fluid (CSF) has attracted interest as an ac-
tive signaling milieu that regulates brain development, 
homeostasis, and course disease. CSF is a nutrient-rich flu-
id, which also contains growth factors and signaling mol-
ecules that regulate multiple cell functions in the central 
nervous system (CNS). CSF constitution is controlled tight-
ly and constituent concentrations are maintained narrow, 
depending on developmental stage. From fetal stages to 
adult life, CSF is produced mainly by the choroid plexus. 
The development and functional activities of the choroid 
plexus, and other blood-brain barrier systems in adults, 
have been extensively analyzed. However, the study of CSF 
production and homeostasis in embryos from the closure 
of the anterior neuropore, when the brain cavities become 
physiologically sealed, to the formation of the functional 
fetal choroid plexus has been largely neglected. This devel-
opmental stage is characterized by tightly controlled mor-
phological and cellular events in the anterior part of the 
CNS, such as rapid brain anlagen growth and initiation of 
primary neurogenesis in the neural progenitor cells lining 
the cavities, events which are driven by specific molecules 
contained within the embryonic CSF. In this article, we re-
view the existing literature on formation and function of 
the temporary embryonic blood-CSF barrier, from closure 
of the anterior neuropore to the formation of functional 
fetal choroid plexuses, with regard to crucial roles that em-
bryonic CSF plays in neural development.
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The central nervous system (CNS) is one of the most in-
triguing systems in vertebrates as it controls many cru-
cial processes in living beings, including complex behav-
ior, and its deterioration underlies a myriad of severe and 
largely incurable diseases. Brain formation begins early on 
during development, when a portion of the dorsal ecto-
derm develops into neural ectoderm, forming the neural 
plate. The neural plate then folds longitudinally to form the 
neural tube, a rudiment of the CNS. The brain develops out 
of its anterior portion and the spinal cord out of its posteri-
or portion (1-3) (Figure 1). The architecture of the brain pri-
mordium also reveals the existence of connected internal 
cavities, the cephalic vesicles, which in fetuses and adults 
become the ventricular system of the brain. During em-
bryonic and fetal development, as well as during adult life, 
these brain cavities and ventricles are filled with a complex 
protein-rich fluid, the cerebrospinal fluid (CSF).
CSF has intrigued philosophers, physicians, and scientists 
for the last 4000 years. The earliest mention of a fluid within 
the brain dates back to ancient Egypt (4). First studies of 
barriers in the brain are attributed to Herophilus (335-280 
BCE), who described the choroid plexus, a highly vascu-
larized secretory epithelium involved in CSF production. 
Similarly, the first reports on CSF functions are attributed 
to Galen of Pergamon (129-200/216), who described an al-
chemical transformation occurring at the base of the brain 
as a “vital spirit” coming from the blood vessels. A gener-
ally accepted hypothesis of CSF physiology is that CSF is 
primarily produced by the choroid plexus from fetal stages 
through to adult life. It is a nutrient-rich fluid containing a 
number of growth factors and other signaling molecules, 
which bathes the brain and the spinal cord and fills the 
ventricles of the brain and spinal canal. The study of CSF 
production and homeostatic control in embryos from the 
closure of the anterior neuropore to the formation of the 
choroid plexus has been largely neglected, although this 
developmental stage plays an important role in brain for-
mation. It is characterized by rapid brain anlagen growth 
and initiation of primary neurogenesis in neural progenitor 
cells lining the cavities.
In this article, we review the existing literature on the for-
mation and function of embryonic blood-CSF barriers, 
from the closure of the anterior neuropore to the forma-
tion of choroid plexuses, and we emphasize their impor-
tance regarding the roles that the embryonic CSF (eCSF) 
plays in neural development.
THE PUZZLING QUESTION OF BARRIER MATURITY
Despite recent efforts to summarize all available informa-
tion in several comprehensive reviews encompassing fetal 
stages through to adulthood (4-11), the subject remains 
FIGURE 1. General central nervous system (CNS) development and brain cavity formation. Main barriers are also shown. General CNS 
development and brain cavity formation is similar in all vertebrates, although these drawings are closer to mammal and avian system.
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somewhat tangled and controversial, especially with re-
spect to brain barrier formation and function during early 
embryonic development. This is partially due to a common 
incorrect belief that barriers in the developing brain are im-
mature (4). Another factor contributing to this is the incon-
sistent terminology used in the literature, which defines 
early embryonic structures as leaky, tightening, or devel-
oping, without considering the actual function they serve 
(7). Thus, according to the traditional concept there is no 
reason why the embryonic brain should require an envi-
ronment of very great chemical constancy for regulated 
barrier mechanisms to exist. This misconception is ampli-
fied by the general term blood-brain barrier (BBB), which is 
commonly used to describe all anatomical barriers of the 
brain, with no clear indication as to which particular bar-
rier is discussed.
A further contributing factor is the way in which blood-CSF 
barrier permeability, usually expressed as the ratio of the 
concentration of particular molecules in the CSF with re-
spect to blood plasma, has traditionally been interpreted. 
For small molecules, this ratio is much higher in the devel-
oping brain than in the adult brain (11-14), and this has 
been misinterpreted as evidence of greater barrier perme-
ability (15-18). However, tight junctions, the morphological 
basis of these barriers, are present from the earliest stages 
of development between endothelial cells of blood ves-
sels in BBB areas (19), as well as in epithelial cells of the 
choroid plexuses in the blood-CSF barrier (20,21). To recon-
cile these two sets of evidence, it has been suggested that 
different transcellular mechanisms for protein and small 
molecule transfer operate across the embryonic blood-
CSF interface (22).
In the past 15 years, a number of studies reported on the 
crucial roles of the eCSF (6,10) before the fetal choroid 
plexus becomes functional. Several proteomic analyses 
results (9) have suggested that eCSF protein composition 
in these early stages of development is tightly regulated 
and dynamic, and it has also been demonstrated that ma-
jor eCSF protein fractions are produced or stored outside 
the cephalic vesicles (23), and thus must be transported 
inside of them, somehow crossing the surrounding neu-
roepithelium, since at this developmental stage they are 
physiologically sealed. All these data contradict the gen-
eral notion that the embryonic brain does not require a 
controlled environment.
There are three major independent barriers in the adult 
brain, which gradually start developing early on in 
fetal stages: 1) the blood-CSF barrier, at the choroid plexus 
epithelial cells; 2) the blood-brain barrier itself at the en-
dothelium of cerebral blood vessels, and; 3) the arachnoid 
barrier between the CSF in the subarachnoid space and 
the dura mater and overlying tissues (Figure 1). The circum-
ventricular organs also form another kind of barrier, allow-
ing linkage between the CNS and peripheral blood flow 
while protecting the CNS from toxic substances. A num-
ber of studies were aimed at investigating the develop-
ment and functional properties of these barriers (7,24), and 
found that the choroid plexus is active from fetal stages of 
development.
Limited information is available on the existence, role, and 
properties of blood-eCSF barriers in embryos at earlier 
developmental stages. It is known that embryos possess 
a temporary barrier between the CSF and brain paren-
chyma, which only functions as a barrier during the early 
stages of brain development (25), but very few research-
ers have investigated the means by which molecules pres-
ent in the eCSF are transported to this fluid (26). How this 
fluid is produced and how its homeostasis is controlled, as 
well as the full range of its functions, continues to be an 
area of intense research, with important implications for 
human health (5).
ARGUMENTS FOR THE PHYSIOLOGICAL NEED FOR A 
BLOOD-eCSF BARRIER FUNCTION
Through its specific molecules the eCSF plays several cru-
cial roles during early stages of brain development just after 
the closure of the anterior neuropore, ie, during initial brain 
anlagen growth and initiation of primary neurogenesis in 
the neural progenitors of the brain primordium. To explain 
the need for barriers controlling eCSF composition and ho-
meostasis before the formation of a functional fetal chor-
oid plexus, we will first briefly summarize the functions and 
composition of this embryonic fluid. In studies where sev-
eral experimental approaches in chick and mouse embryos 
were used, it was found that eCSF exerted positive pres-
sure against neuroepithelial walls, generating an expansive 
force and consequently contributing to the expansion of 
the brain (27,28). It was suggested that the molecules that 
mediate this function were chondroitin sulfate proteogly-
cans and other proteoglycans contained within the eCSF, 
because of their special osmotic properties (29,30). They are 
also major components of the extracellular matrix in em-
bryo brain cavities and have a role in facilitating water re-
tention inside the cavities and thereby generate and regu-
late the inner cephalic hydrostatic pressure.
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A study using in vitro cultures of mesencephalic neuroec-
todermal explants from chick embryos at HH24 (corre-
sponding to embryonic day E4) demonstrated that diffus-
ible molecules contained within eCSF actively contributed 
to the regulation of survival, proliferation, and neurogen-
esis of neuroepithelial progenitor cells (31). Similarly, it was 
also demonstrated that diffusible molecules contained 
within the eCSF actively contributed to the regulation of 
expression of particular mesencephalic genes, together 
with the well-known mesencephalic-telencephalic isth-
mus organizer (32).
Proteomic studies have demonstrated that the eCSF pro-
teome consists of dozens of extracellular matrix proteins, 
osmotic pressure regulators, ion carriers, hormone-binding 
proteins, lipid metabolism regulators, and various enzymes 
and their regulators (33-38), and that it shares many simi-
larities across species during brain development. Conven-
tional proteomic techniques (2D-electrophoresis, in-gel 
digestion and Electrospray Ionization Mass Spectrometry- 
analysis) have been used to identify and analyze the eCSF 
proteome from chick embryos at developmental stage E4, 
corresponding to maximum neuroepithelial progenitor cell 
proliferation period and the beginning of neural differenti-
ation (36). Twenty-six proteins contained within eCSF were 
recognized, identified, and classified into eight groups ac-
cording to their functional characteristics: 1) gene products 
related to extracellular matrix proteins, 2) proteins associat-
ed with regulation of osmotic pressure and ion transport, 
3) proteins related to cell quiescence and death, 4) lipid 
transport or metabolism proteins, 5) retinol and vitamin D 
carriers, 6) antioxidant and antimicrobial proteins, 7) intra-
cellular proteins, and 8) unknown proteins.
The mammalian eCSF proteome was analyzed in several 
organisms, including rats and humans. Using the same 
methods as in chick eCSF proteome analysis (35), thirty-
one proteins were identified in rat eCSF and analyzed at 
an equivalent developmental stage (E12.7, initiation of pri-
mary neurogenesis in the brain anlagen). As with the chick 
eCSF proteome, these proteins included extra-cellular ma-
trix proteins, gene products associated with the regulation 
of osmotic pressure and ion transport, lipid metabolism 
regulators, retinol and corticosteroid carriers, as well as 
antioxidant and antimicrobial proteins. However, rat eCSF 
also contains a group of proteins that have no functional 
homologues in chick eCSF, ie, enzymes and enzyme regu-
lators. Moreover, it exhibits an increased number of mem-
bers of the apolipoprotein family. An extensive proteome 
analysis of rat eCSF from three different stages, ie, E12.5, 
E14.5 (taken from both lateral ventricle and 4th ventricle) 
and E17.5, identified 423, 318, 249, and 382 proteins, re-
spectively. All proteins were again classified into several 
groups according to their function: extracellular matrix 
proteins; regulatory molecules, mainly protease inhibitors; 
cell adhesion proteins; nucleic acid binding proteins; trans-
fer/carrier proteins; immune/defense proteins; receptors; 
and enzymes (37).
Most of the identified proteins have known physiological 
functions during embryonic development that are consis-
tent with the overall reported roles for eCSF during CNS 
development. Functional analyses, both in vivo and in vit-
ro, of the particular role of some of these gene products 
at the beginning of primary neurogenesis, before the for-
mation of the choroid plexuses, have revealed their spe-
cific roles in the overall function of eCSF in neuroepithelial 
progenitor cell behavior. For example, it has been reported 
that the deglycosylation of eCSF proteoglycans with beta-
d-xyloside alters brain enlargement in chick embryos (29), 
and that the immunoblocking of the FGF2 contained with-
in eCSF disrupts neuroepithelial stem cell proliferation and 
differentiation (39). Similarly, it has also been reported that 
the low-density lipoprotein lipid fraction, which is trans-
ported by the apolipoprotein B contained within eCSF, is 
also involved in neuroepithelial progenitor cell prolifera-
tion and differentiation (40).
Other research has shown that retinol-binding protein 
(RBP) transports and transfers all-trans retinol from the 
embryonic plasma to the eCSF, from where it reaches the 
neuroepithelium and is transformed into retinoic acid, the 
actual morphogen, by retinoic acid-synthesizing enzymes 
expressed in the neuroepithelium (41,42). This transport 
from the blood plasma to the eCSF has also been demon-
strated for other molecules, such as FGF2. Intravascularly 
injected FITC-conjugated FGF2 passes into the eCSF in a 
regulated manner, whereas control proteins normally not 
present in the eCSF of similar size and also conjugated to 
FITC do not have the capacity – or are not allowed – to 
cross from the blood plasma to the eCSF. In fact, it has also 
been demonstrated that major eCSF protein fractions are 
transported from plasma to cephalic vesicles (23) in a de-
velopmental stage in which the brain cavities are physi-
ologically sealed due to the neuroectoderm morphology, 
which includes specific tight junctions. Taken together, all 
these data suggest a need for a physiological blood-eCSF 
barrier that controls the initial composition and homeo-
stasis of eCSF, before the formation of functional fetal 
choroid plexuses. Most probably this blood-eCSF 
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barrier should be physiologically and morphologically 
different from those of adults and older fetuses, as it may 
serve specific functions in embryos and must be adapted 
to developing morphological features.
MORPHOLOGICAL AND PHYSIOLOGICAL 
CHARACTERISTICS OF THE INITIAL TEMPORARY BLOOD-
eCSF BARRIER
In adults, there are multiple loci of the blood-CSF barrier 
that control the internal environment of the brain, as both 
the stability and specificity of this environment are essen-
tial for normal brain development and function (43). They 
significantly impede the passage of virtually all molecules 
from the blood to the CSF, except for small and lipophilic 
ones. However, some sets of small and large hydrophilic 
molecules, such as proteins, can enter the CSF by active 
transport. Some of these transport systems are known to 
be receptor-mediated, eg, by the transferrin receptor (44) 
and there is evidence that other growth factors and cytok-
ines have limited ability to cross blood-CSF barriers (24). 
Likewise, there are specific transmembrane transporting 
molecules, present in relatively high concentrations in 
these endothelial cells, for essential nutrients such as glu-
cose and certain amino acids, vitamins, and ions. Underly-
ing the cellular mechanisms that determine the CSF envi-
ronment is a fundamental physical barrier at the level of 
intercellular junctions between cells forming the interface 
between the blood and the CSF.
On the basis of theoretical considerations, extensive lit-
erature, and a growing amount of experimental evidence, 
it has been argued that during fetal development, the 
blood-CSF barrier at the level of the developing choroid 
plexus restricts passage of lipid-insoluble molecules such 
as gene products by the same mechanism as in the adult, 
ie, by tight junctions, rendering the paracellular pathway 
an unlikely route of entry (7). It has also been suggested 
that proteins are transferred through transcellular routes. 
Thus, a concept of a functional and dynamic barrier differ-
ent from that of the adult was introduced, since it is adapt-
ed to specific requirements and environment of the early 
developing nervous system. However, the question still re-
mained of the control of eCSF composition and homeosta-
sis from the closure of the anterior neuropore and before 
the formation of the functional fetal choroid plexus.
A number of studies published during the last 6 years 
conducted primarily on chick embryos from E3 to E5 
but also in some cases on rat embryos at an equiva-
lent developmental stage (from E12.7 to E13.7) have dem-
onstrated the existence of a functional and dynamic bar-
rier formed by endothelial cells of specific blood vessels as 
well as by columnar cells of the differentiation neuroepi-
thelium, which acts from the closure of the anterior neu-
ropore, at the beginning of brain primary neurogenesis. 
This barrier temporarily restricts the passage of lipid-insol-
uble molecules from the blood to the eCSF and vice versa, 
thus contributing to eCSF formation and homeostatic con-
trol before the choroid plexus becomes functionally active, 
ie, it is a specific blood-eCSF barrier that contributes to the 
brain’s internal milieu at this crucial stage of development.
The impermeability of the cephalic neuroectoderm: a 
key factor for blood-eCSF barrier activity
One of the key factors why a specific blood-eCSF barrier 
is needed before the formation of a functional fetal chor-
oid plexus is the impermeability of the cephalic neuroec-
toderm, which forms an internal, physiologically sealed 
system of the brain cavities. Early experiments on testing 
the integrity of this barrier in embryos and fetuses used 
injected dyes or enzymes, usually trypan blue, Evans blue, 
or horse-radish peroxidise (HRP), paralleling experiments 
performed on adults. The injection of dyes gave conflict-
ing results, probably due to different amounts of solution 
injected into fragile and small embryos (45). Other possible 
explanations are that dyes reversibly bind to plasma pro-
teins, so the usage of too much of it can result in the move-
ment of unbound dye, which has been shown to be able 
to pass through many barrier cell types; or facilitated trans-
port of the protein-bound dye.
With respect to HRP, it was shown more than 30 years ago 
that blood-eCSF and blood-fCSF interface permeability for 
this molecule in chick embryos began to decrease at E12-
E14, ie, 8 to 10 days after the initiation of primary neuro-
genesis, when the fetal choroid plexus was already fully 
active (46). According to these experiments, younger em-
bryos may have a free diffusion system for protein trans-
fer between these two embryonic compartments. Howev-
er, it has recently been demonstrated that the transfer of 
all other proteins examined to date from the blood plas-
ma to the eCSF is regulated by an active barrier function 
(47). Why HRP, in contrast to all other proteins examined, 
is transferred from the blood plasma to the eCSF, has not 
been yet satisfactorily explained, but it could be related to 
the presence in chick eCSF of other enzymes with peroxi-
dase activity, which are apparently transported across this 
barrier (36,47).
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Another set of recent findings has also demonstrated that 
the neuroectoderm of chick embryos is physiologically 
sealed to small molecules from E4, suggesting the pres-
ence of some kind of blood-eCSF barrier controlling their 
transport. The microinjection of a small-sized tracer, biotin 
dextran amine of 3 kDa (BDA3000), into the cephalic cav-
ity, or conversely into the outflow of the heart of embryos 
at E3 (HH20) and E4 (HH23), showed that at E3 this trac-
er was transferred between the eCSF and the blood plas-
ma and vice versa throughout neuroepithelial cells of the 
brain cavities, but that from E4 this transport was restricted 
to a small subset of endothelial and adjacent neuroepithe-
lial cells. This subset of cells is located in the ventral mes-
encephalon and in the most anterior part of the ventral 
prosencephalon, lateral to the floor plate (47) (Figure 1). 
Moreover, histological analysis has shown that in chick em-
bryos at E4, BDA3000 is transported following transcellular 
routes, which accounts for a physiologically sealed system 
and suggests the existence of endothelial and neuroepi-
thelial cells specialized in the transport of molecules from 
the blood plasma to the eCSF and vice versa. The existence 
of these specialized cells is a key factor for blood-eCSF bar-
rier activity. This situation parallels the functioning of the 
fetal choroid plexus, as demonstrated by mounting evi-
dence (14,22,48,49).
Transport of proteins from the blood plasma to the 
eCSF and vice versa: a crucial factor for eCSF stability
It has been reported that from E3, eCSF has a complex pro-
tein composition that differs from that of blood plasma, 
and that the relative concentration of these proteins var-
ies during development and with respect to adult CSF (50-
54). Initially, eCSF derives from trapped amniotic fluid, but 
after the closure of the anterior neuropore, the brain cavi-
ties become a physiologically sealed system, allowing tight 
regulation of its composition. Thus, at least shortly after the 
closure of the anterior neuropore, some of the eCSF com-
ponents may be attributed to encapsulated amniotic fluid, 
although to date no specific studies have been made re-
garding their putative influence of brain development.
It has also been demonstrated that at E4, chick eCSF pro-
teome includes molecules whose role during the devel-
opment of systems other than the eCSF may account for 
general functions of this fluid, as described above (36,39). 
Interestingly, most of the molecules identified in chick 
eCSF are not produced by the neuroectoderm itself, but 
by other embryonic structures, or alternatively they are 
stored in the yolk or the white of the egg and taken up 
by the chorioallantoic membrane (23,39), suggesting that 
they are transported from the production or storage site to 
the eCSF, probably via the blood plasma.
Various experiments have demonstrated that the transport 
of proteins from the blood plasma to the eCSF and vice 
versa in chick embryos at E4 and E5 is tightly regulated, as 
is homeostatic control, which is crucial for eCSF function 
in brain development (47,55). These experiments included 
the quantification of endogenous chick proteins present 
in both the blood plasma and the eCSF (ovalbumin, retin-
ol-binding protein, fibroblast growth factor No. 2, and im-
munoglobulin IgY), as well as the microinjection of several 
proteins of different molecular size into the brain cavities or 
alternatively into the outflow of the heart of chick embryos 
at E4. In the microinjection experiments, the proteins used 
included both endogenous chick proteins normally pres-
ent in the eCSF or conversely not normally detected with-
in this fluid, and proteins from sources other than chicks 
(bovine serum albumin, myosin heavy chain from rabbit, 
fibroblast growth factor No. 2, plasma retinol-binding pro-
tein, a recombinant protein from glutathione-S transferase 
– from Schistosoma japonicum, alcohol dehydrogenase – 
from Drosophila lebanonensis, and ovalbumin).
These experiments demonstrated that the physiologi-
cal ratio of chick endogenous proteins between the eCSF 
and the blood plasma was regulated developmentally, as 
they varied from E3 to E5 in a regulated manner accord-
ing to their activity in brain development (47). For example, 
the eCSF/blood plasma ratio for retinol-binding protein is 
much higher at E4 than at E3 or E5, coinciding precisely 
with its reported activity in retinol transport from the blood 
plasma to the eCSF (41), while for fibroblast growth factor 
No. 2, the eCSF/blood plasma ratio is higher at E5 than at 
E3 or E4, also coinciding with the developmental period in 
which this growth factor acts from the eCSF to influence 
neuroepithelial progenitor cell proliferation (39).
These sets of experiments also demonstrated that the 
transfer of both chick endogenous proteins and microin-
jected proteins across the blood-eCSF interface was high-
ly protein-specific (47). For example, chick IgY has never 
been observed to be transported from the blood plasma 
to the eCSF, even when its concentration within the blood 
plasma was experimentally raised by microinjection. Simi-
larly, none of the proteins from sources other than chick, 
as for example BSA or the recombinant protein glutathi-
one-S transferase/alcohol dehydrogenase, were trans-
ported from the blood plasma to the eCSF when ex-
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perimentally microinjected into the outflow of the heart 
(with the exception of HRP). Conversely, when chick pro-
teins that under normal physiological conditions are trans-
ported between these two embryonic compartments, as 
for example ovalbumin, fibroblast growth factor No. 2, and 
retinol-binding protein, were experimentally microinject-
ed into the outflow of the heart – properly linked to FITC to 
allow their identification with respect to the endogenously 
produced equivalent proteins – they were actively trans-
ported across the blood-eCSF interface (47).
Interestingly, these experiments also demonstrated that 
the ratio of transfer for these proteins was tightly regulat-
ed. In other words, eCSF homeostasis is strongly controlled 
to maintain fluid stability (47). For example, the transporta-
tion from the blood plasma to the eCSF of the above-men-
tioned proteins linked to FITC did not involve any increase 
in their concentration within the brain cavities, which re-
mained stable. Moreover, the experimental microinjection 
of these chick endogenous proteins into the cephalic cav-
ities to directly raise their concentration within the eCSF 
was rapidly compensated for by the eCSF-blood plasma 
transport system, which eliminated the excess of proteins 
in the eCSF within minutes, restoring their normal concen-
tration. Similarly, when the microinjected proteins came 
from sources other than chick, they were rapidly eliminat-
ed from the eCSF. All these data strongly suggest the ex-
istence of a blood-eCSF barrier activity before the forma-
tion of the functional fetal choroid plexus, acting in both 
directions to control eCSF formation and homeostasis. In 
addition, it has also been demonstrated that this precise 
regulation of protein transport and eCSF homeostasis en-
sures maximum efficiency of eCSF activity during neural 
development (55).
A histological analysis of embryos when transporting en-
dogenous proteins linked to FITC or alternatively proteins 
from sources other than chick demonstrated that within 
the analyzed developmental period their transfer from the 
blood plasma to the eCSF and vice versa occurred only at 
a specific embryo area located in the brain stem lateral to 
the floor plate, in the ventral mesencephalon and the most 
anterior part of the ventral prosencephalon (Figure 1). This 
location does not coincide with the area were the fetal 
choroid plexus starts to develop, from an invagination of 
the dorsal roof plate along the midline of the neural tube, 
indicating that this transient embryonic blood-eCSF bar-
rier function is independent of the choroid plexus, and 
suggesting that it fulfills the function temporarily lack-
ing from the formation of physiological sealed brain 
cavities to the initiation of choroid plexus activity. More-
over, histological analysis also showed that this blood-
eCSF barrier function includes endothelial cells of specific 
perineural blood vessels as well as some vascular sprouts 
located within the neuroectoderm cells and adjacent neu-
roepithelial cells, using transcellular routes (47).
Immunohistological analysis has revealed the presence of 
caveolin 1 in endothelial cells of blood vessels involved in 
the blood-eCSF barrier function as well as in the adjacent 
neuroectodermal cells (56). Caveolin 1, a member of the 
caveolin family of proteins, is the main structural compo-
nent of caveolae, which are 50- to 100-nm vesicular in-
vaginations of the plasma membrane that are involved in 
transcellular molecular transport, including trancytosis as 
well as endocytosis, cell adhesion, and signal transduction 
(57). The presence of caveolin 1 also suggests that these 
tissues are involved in the transport of molecules from the 
blood plasma to the eCSF and vice versa, a transport which 
is highly regulated as shown in different experiments (47). 
Endothelial cells usually show the highest expression of ca-
veolin 1 (58), which is also found in the human BBB-pro-
vided vessels (59). Interestingly, caveolin 1 has also been 
detected in the same embryonic area in rat embryos at an 
equivalent developmental stage (E12.7), including paral-
lel blood vessels and their adjacent neuroectodermal cells 
(56). Although few data are available on protein transport 
from the blood plasma to the eCSF at this developmental 
stage in mammals, the presence of caveolin 1 in the very 
same region involving both endothelial and neuroepithe-
lial cells has led to speculation on the existence of a barrier 
function in mammals acting in the same way as demon-
strated in chick embryos (56).
Water, ion, and glucose transport: from eCSF formation 
to function in brain development
During early CNS development, the increase in brain cav-
ity volume is accompanied by a parallel increase in eCSF 
volume (6), rendering the control of water flux and regu-
lation of solute transport critical. Rapid membrane water 
transport is mediated by a family of transmembrane pro-
teins that form molecular water channels, the so-called 
aquaporins (AQPs), which have been identified in epithelial 
and endothelial cells at numerous locations in higher ver-
tebrates (60-65). Of the 12 AQPs described to date (AQP0 
to AQP11), AQP-1, AQP-4, and AQP-9 play a relevant role in 
water transfer in the adult brain (64), and AQ1 and AQ4 also 
play a role in water transport across brain barriers. AQ1 has 
been shown to be expressed at very early stages of chor-
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oid plexus development in a range of mammalian species, 
including humans (65), and it has been reported that AQ4 
is present in adult brain endothelial cells (66), although this 
is still under debate. Findings from several studies suggest 
that choroid plexus apical expression of AQP-1 is closely re-
lated to the rate of CSF formation. For example, AQP-1 null 
mice have lowered CSF formation and pressure (67).
Similarly, ion transfer appears to be critical for eCSF pro-
duction and brain anlagen growth. Ions can move through 
cell membranes both actively by ion pumps and passive-
ly via ion channels. In the adult, the ionic composition of 
the brain environment is kept very stable as this is essential 
for normal nerve conduction. Fluctuations in blood ionic 
levels are not reflected in fluctuations within the CNS and 
there are clear ion gradients between blood and the brain 
(43). Also in adults, AQP4 co-localizes with the inwardly 
rectifying K+ channel Kir4.1 (68), and it has been suggest-
ed that together, these two proteins play a key role in K+ 
and water balance. However, very few data are available 
on developing embryos. For example, the presence of a 
Cl− and Mg++ ionic gradient between CSF and brain has 
been reported in sheep embryos at E44–50 (term is 150 
days), indicating the presence of an effective ion pump 
mechanism (69).
A study using immunohistochemical procedures and poly-
merase chain reaction (PCR) analysis revealed that AQP1, 
AQP4, and Kir4.1 were present in chick and rat embryos 
in the very same blood vessels where specific protein 
transport was also detected (70). In chick embryos, AQP1 
is present from E4, and AQP4 and Kir4.1 from E5. Interest-
ingly, these specific transporters are also detected in rat 
embryos at equivalent developmental stages; AQP1 is de-
tected from E12.7 and AQP4 and Kir4.1 from E13.7. These 
data confirm that a blood-eCSF barrier function controls 
eCSF composition and homeostasis from the early stag-
es of brain development in chick embryos, including wa-
ter and ion influx, thus regulating E-CSF osmolarity, and 
it has been proposed that a similar blood-eCSF barrier is 
also present in mammals at equivalent brain development 
stages (56,70), although no data on protein transport are 
available in these organisms at these early stages of brain 
development.
Apart from water and ion influx, transport of molecules as 
energy sources for the developing neuroepithelium is also 
of high importance. Glucose is an important energy source 
for the brain, although to a lesser extent in the fetus than 
in the adult (71). Glucose is transported across cell mem-
branes mainly by the GLUT family of solute carriers, includ-
ing GLUT1, which in adults is located in the brain barriers. It 
has also been reported that choroid plexus epithelial cells 
also express GLUT1, starting shortly after they have differ-
entiated (24). Similarly, a study using immunohistochemi-
cal procedures and PCR analysis has demonstrated that in 
chick and rat embryos, GLUT1 is also present in the very 
same blood vessels where protein transport and the pres-
ence of AQP1, AQP4, and Kir4.1 have been detected (70), 
supporting the roles ascribed to the blood-eCSF barrier in 
early brain development with respect to eCSF formation 
and homeostasis.
CONCLUDING REMARKS
The importance of the blood-eCSF barrier for 
controlling eCSF composition and homeostasis in early 
brain development
The ionic stability, neurochemical environment, and nor-
mal functioning of the brain are crucially dependent on 
the integrity of its barrier systems in adults as well as dur-
ing development. The importance of the blood-eCSF bar-
rier in the control of eCSF composition and homeostasis, 
and thus, indirectly, in early brain development, has also 
been tested by disrupting it with chemical procedures (72). 
Chick embryos were treated with 6-aminonicotinamide 
gliotoxin (6-AN), a known antimetabolite of nicotinamide 
that blocks protein transport across the BBB (73) by halt-
ing transcellular caveolae transport, and it was found that 
the lack of protein transport across the blood-eCSF barrier 
clearly influences neuroepithelial cell survival, proliferation, 
and neurogenesis. This blockage also disrupts water influx 
to the eCSF, altering brain anlagen growth.
The roles ascribed to the early and temporary blood-eCSF 
barrier functions reviewed in this paper confirm the crucial 
importance of the eCSF milieu for the developing brain at 
the initiation of primary neurogenesis, after the closure of 
the anterior neuropore and before the fetal choroid plexus 
starts to be fully functional. They also strongly suggest that 
this transient barrier function should be considered as an 
actual barrier system, operating in early embryos at a spe-
cific location and comprising both endothelial cells of par-
ticular blood vessels and the adjacent neuroectodermal 
cells. This barrier system, which operates transcellularly, in-
cludes specific transporters for particular molecules, such 
as aquaporins, as well as transporters for ions and glu-
cose. The highly specific protein transport by the cave-
olae system also suggests the presence of particular 
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transporters for proteins, in order to discriminate among 
proteins and also to detect their concentration within the 
eCSF, as the homeostasis of this fluid is tightly regulated.
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